Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn the core crypto basics and the key holdings a beginner should own, plus tips to manage risk and start a balanced portfolio.
25,015 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Delek Logistics Partners has logged 13 years of rising payouts, but 2025 cash flow barely covers distributions, promp...
Oil hovers around $100 a barrel on March 25, 2026, as traders weigh demand growth against supply risks. The piece exp...
Wall Street is rotating away from AI momentum toward steady, long-running dividend payers. The beaten-down dividend a...
Regional markets back demand remains resilient as rate pressure builds, with Texas leading loan activity and Californ...
A major brokerage lifts its price target for ASML to near $2,000, citing surging EUV demand from DRAM makers and a sw...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...
Disney's stock is under renewed pressure as its core businesses face slower growth. The market is awaiting clearer pr...
Tesla stock slides as delivery fears collide with SpaceX IPO chatter and a Cybercab roadmap, leaving investors weighi...
The latest data show the U.S. public debt now tops the nation's GDP, a milestone with potential implications for rate...
Oklo shares jumped after the NRC cleared a foundational design criterion for the Aurora project, boosting the nuclear...
The US dollar still dominates oil trades, but signals of strain are rising. Tensions in the Middle East and a push to...